MUSTAFA I NAEEM
TOMBALL, TX NPI 1740243153
Browse related groups: TX Mylan Specialty L.P. All categories
General Payments — all program years on this page
$4,441.72
- Category: General Payments
- Program years: PY2018–2024
- Record count: 244
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $694.32 across 30 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $694.32 | 30 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Mylan Specialty L.P. | $168.25 | 6 |
| Acerta Pharma LLC | $164.95 | 8 |
| Shionogi Inc | $110.18 | 6 |
| GlaxoSmithKline, LLC. | $101.53 | 5 |
| Biosense Webster, Inc. | $67.90 | 1 |
| Relypsa, Inc. | $26.37 | 1 |
| Pulmonx Corporation | $19.75 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.71 | 1 |
| GENZYME CORPORATION | $17.68 | 1 |
By program year
Records — PY2024 (30)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.